Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
The University of Basel, Switzerland, invites applications for a PhD researcher position (100% FTE) for the project Aspirational Urbanism and the Recodification of Defiance (ASPIRA). The function
-
, Quaternary Science, Palaeoecology, or a related field. Experience in palaeolimnology, palaeoecology, limnology, microfossil analysis and/or sediment work would be an advantage. Candidates should hold a valid
-
characterization is highly appreciated. We are looking for committed and creative individuals able to work in a team. The candidate will work in a top-level research environment with state-of-the-art laboratory
-
how perishable biological products react inside cold chain unit operations and to pinpoint why some products decay faster. For that purpose, we develop digital twins of the cargo, based on measured air
-
of Basel, Swiss TPH combines research, education and services at local, national and international levels. 950 people from 95 nations work at Swiss TPH focusing on infectious and non-communicable diseases
-
. Demonstrated aptitude for scientific creativity and non-conventional thinking. Fluent in written and oral English. Self-motivated, critical-thinking, open-minded and communicative, with a strong interest to work
-
is a key-enabling technology for advanced manufacturing. In order to address increasingly complex demands on joining (dissimilar materials combinations, miniaturisation, extreme operation conditions
-
. Empa is a research institution of the ETH Domain. The Laboratory of High Performance Ceramics is offering a PhD position focused on the development of new catalytic materials for CO2 conversion
-
. Empa is a research institution of the ETH Domain. Your tasks Your tasks will focus on the design and operation of experiments to investigate the failure mechanisms in wooden structures. This will require
-
of this project, you will work with a team of scientists with backgrounds in chemistry, cell biology and microbiology as well as with clinical partners on the development of engineered corneal transplant to treat